A 52-week, randomized, open-label study of aripiprazole versus blonanserin in the treatment of Japanese schizophrenia patients

Authors :: Hikaru Hori
Yuki Konishi
Kiyokazu Atake
Reiji Yoshimura
Ryohei Igata
Asuka Katsuki
Source :: Clinical Neuropsychopharmacology and Therapeutics. 8:16-24
Publication Year :: 2017
Publisher :: The Japanese Society of Clinical Neuropsychopharmacology, 2017.

Subjects :: medicine.medical_specialty
business.industry
Blonanserin
medicine.disease
law.invention
Psychiatry and Mental health
Open label study
Randomized controlled trial
Schizophrenia
law
Internal medicine
medicine
Pharmacology (medical)
Aripiprazole
Neurology (clinical)
business
medicine.drug

Full Text Access

Tools